Treatment algorithm based on the multivariate survival analyses in patients with advanced hepatocellular carcinoma treated with trans-arterial chemoembolization
Table 2
Demographics, etiology, staging, liver disease, imaging characteristics and laboratory findings of the patients with advanced (BCLC C) HCC before 1st TACE treatment and corresponding survivals from 1st TACE.